Clinical Trial Update: Effect of Immunosuppression in IgA Nephropathy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial from Yonsei University is evaluating the effects of immunosuppression in biopsy-proven IgA nephropathy, with the current status unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iga Nephropathy

Snippet

Sponsor: Yonsei University | Conditions: Biopsy-proven IgA Nephropathy | Phase 4 | Status: UNKNOWN